Andrea Newkirk
Stock Analyst at Goldman Sachs
(3.03)
# 1,284
Out of 5,146 analysts
4
Total ratings
100%
Success rate
97.42%
Average return
Main Sectors:
Stocks Rated by Andrea Newkirk
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| SDGR Schrödinger | Initiates: Neutral | $19 | $11.80 | +61.02% | 1 | Sep 30, 2025 | |
| RVMD Revolution Medicines | Maintains: Buy | $65 → $73 | $103.24 | -29.29% | 2 | Sep 12, 2025 | |
| ALKS Alkermes | Initiates: Buy | $43 | $31.04 | +38.53% | 1 | Jul 15, 2025 |
Schrödinger
Sep 30, 2025
Initiates: Neutral
Price Target: $19
Current: $11.80
Upside: +61.02%
Revolution Medicines
Sep 12, 2025
Maintains: Buy
Price Target: $65 → $73
Current: $103.24
Upside: -29.29%
Alkermes
Jul 15, 2025
Initiates: Buy
Price Target: $43
Current: $31.04
Upside: +38.53%